BriefTea
Every story in sixty words
Get the free app no ads · no paywallGeneral · 9 June 2026
Kaihsu Tai via Wikimedia Commons (CC BY-SA 3.0)
Investors saw London’s main share index slip as GSK shares fell after announcing a major purchase. On Tuesday, the drugmaker said it plans to buy U.S. cancer drug developer Nuvalent for $10.6 billion, while the FTSE 100 dropped 0.3% and the FTSE 250 added 0.2%. By 0810 GMT, the benchmark stood at 10,341 points and GSK stock was down 2.8%.
Reported by Reuters · How we write briefs
Understand this story
What is the FTSE 100? FTSE 100 explained What's the FTSE 100?More briefs
WorldKatie Zacharia leaves White House press secretary job after just five days WorldJamaica's slavery reparations case gets a London court date in March 2027 WorldSingapore threatens to prosecute firms behind Indonesia's worst fires in years as smoke spreads WorldFlash floods destroy villages in central Nepal TechnologyMeta releases Muse Spark Open, a new ‘open-weight’ AI model WorldIMF chief says AI needs safeguards before it runs people over More top stories → Browse all stories →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.